A looming ‘patent cliff’ could trigger a wave of biotech mergers and acquisitions, but innovation has also been humming along and could lift some stocks.
Related Posts
Watch out. Analysts have been cutting earnings estimates on these stocks reporting next week
Several stocks, like Tesla and Centene, have seen their earnings estimates cut by at least 10% over the past three and six months.
PepsiCo earnings beat estimates even as U.S. demand falls
PepsiCo reiterated its full-year outlook after its quarterly earnings and revenue topped estimates.
Here are Tuesday’s biggest analyst calls: Nvidia, Apple, AMD, Victoria’ Secret, Uber, Target, Broadcom, Lululemon & more
Here are the biggest calls on Wall Street on Tuesday.